Generated by AI
ABVC Biopharma Inc. is a clinical-stage biopharmaceutical company focused on developing new drugs and medical devices derived from plants. The company works across therapeutic areas including central nervous system disorders, oncology, hematology, and ophthalmology, using botanical science and licensed research to advance candidates through early and mid-stage clinical development. Its current portfolio includes multiple drug programs and medical devices designed to address unmet medical needs, with an emphasis on proof-of-concept studies and collaborative development. ABVC Biopharma also operates an asset-light model that relies on licensing, partnerships, and clinical trial execution to move products toward commercialization. Headquartered in Fremont, California, ABVC Biopharma serves as a specialized participant in the broader biotechnology market, combining plant-based innovation with drug and device development.
Website44370 Old Warm Springs Boulevard
Fremont, CA, 94538
United States
The latest articles about ABVC.
Find the latest ABVC BioPharma, Inc. (ABVC) stock quote, history, news and other vital information to help you with your stock trading and investing.
Summary of Jul 8's posts. Generated by AI.
Summary of Apr 25's posts. Generated by AI.
Summary of Oct 26's posts. Generated by AI.
Investors talking about ABVC also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.